Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Predictive Oncology ( (POAI) ) has shared an update.
Predictive Oncology has scheduled its 2025 annual meeting of stockholders for November 25, 2025, at DLA Piper LLP’s offices in Pittsburgh, Pennsylvania. The company has set October 24, 2025, as the record date for determining stockholders eligible to vote. Stockholders have until October 26, 2025, to submit proposals for consideration at the meeting. The company plans to distribute proxy materials around November 3, 2025, and may adjust these materials or the meeting date based on proposals received.
The most recent analyst rating on (POAI) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.
Spark’s Take on POAI Stock
According to Spark, TipRanks’ AI Analyst, POAI is a Neutral.
The overall stock score is primarily impacted by significant financial challenges, including declining revenues and negative profit margins. Technical analysis indicates a bearish trend, and poor valuation metrics further contribute to the low score. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on POAI stock, click here.
More about Predictive Oncology
Average Trading Volume: 84,494
Technical Sentiment Signal: Sell
Current Market Cap: $10.37M
Learn more about POAI stock on TipRanks’ Stock Analysis page.